PenderFund Capital Management’s Avidity Biosciences RNAM Stock Holding History

PenderFund Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,500	Closed	-$325K	–	291
2025 Q4	$325K	Buy	+4,500	New	+$291K	0.05%	89

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

PenderFund Capital Management's RNAM Position: Q1 2026 in Review

PenderFund Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,500 shares — an estimated $325K sold.

PenderFund Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $325K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

PenderFund Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
PenderFund Capital Management sold 4,500 Avidity Biosciences shares in Q1 2026, an estimated $325K.
PenderFund Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
PenderFund Capital Management's Avidity Biosciences position peaked at $325K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on PenderFund Capital Management's 13F filing for Q1 2026, filed 15 May 2026.